Federica Sella

A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma

Florentia Dimitriou, Phil F. Cheng, Annalisa Saltari et al. · Nature Cancer · 2024 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Excision repair cross‐complementation group 1 protein expression predicts survival in patients with high‐grade, non‐metastatic osteosarcoma treated with neoadjuvant chemotherapy

Claudia Maria Hattinger, Francesca Michelacci, Federica Sella et al. · Histopathology · 2015 · 23 citations · Full text

Medicine, Oncology, Pathology +17

Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma

Lorenza P. Ferretti, Flurina Böhi, Deena M. Leslie Pedrioli et al. · Cancer Research · 2023 · 19 citations

Medicine, Cancer Biology, Oncology +17

LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

Sarah Proteau, Imène Krossa, Chrystel Husser et al. · EMBO Molecular Medicine · 2023 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma

Ulrike Lischetti, Aizhan Tastanova, Franziska Singer et al. · Communications Biology · 2023 · 14 citations · Full text

Life Sciences, Cell Biology, Oncology +17